Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome

被引:9
|
作者
Hasegawa, E. [1 ]
Sato, H. [1 ,2 ]
Wada, Y. [1 ]
Takai, K. [3 ]
Wakamatsu, A. [1 ]
Nozawa, Y. [1 ]
Nakatsue, T. [1 ]
Kuroda, T. [2 ]
Suzuki, Y. [2 ]
Nakano, M. [4 ]
Narita, I. [2 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan
[2] Niigata Univ, Hlth Adm Ctr, Niigata, Japan
[3] Niigata City Gen Hosp, Div Hematol, Niigata, Japan
[4] Niigata Univ, Sch Hlth Sci, Dept Med Technol, Fac Med, Niigata, Japan
关键词
TAFRO syndrome; systemic lupus erythematosus; interleukin-6; vascular endothelial growth factor; MULTICENTRIC CASTLEMANS-DISEASE; CLINICAL-FEATURES; KOJIMA DISEASE; CYCLOSPORINE-A; ONSET; THROMBOCYTOPENIA; TOCILIZUMAB; CLASSIFICATION; MYELOFIBROSIS; ANASARCA;
D O I
10.1177/0961203317725589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose TAFRO syndrome is a novel disorder manifesting as fever, anasarca, thrombocytopenia, renal insufficiency and organomegaly, and its etiology has not been clarified. The aim of this study was to elucidate similarities and differences between systemic lupus erythematosus (SLE) and TAFRO syndrome. Methods We examined 46 consecutive patients diagnosed with SLE and determined whether they meet the proposed diagnostic criteria for TAFRO syndrome (2015 version). Results Of the 46 patients with SLE, four (8.7%) also met the TAFRO syndrome criteria (TAFRO-like group). All patients in the TAFRO-like group were males, and their mean age was significantly higher than that of the non-TAFRO group (67.58.7 vs. 39.3 +/- 18.1 years, p=0.004). C-reactive protein and -glutamyl transpeptidase levels were significantly higher, and frequencies of anti-dsDNA and anti-Sm antibodies were significantly lower in the TAFRO-like than non-TAFRO group. Elder cases (onset age50 years) met significantly more categories of the diagnostic criteria for TAFRO syndrome than did those with younger cases. Conclusions Several patients with SLE, especially elder cases, showed features similar to those of TAFRO syndrome. Although exclusion of SLE is needed in the diagnostic criteria for TAFRO syndrome, TAFRO syndrome-like SLE should be considered.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 50 条
  • [21] American College of Rheumatology criteria for systemic lupus erythematosus exclude half of all systemic lupus erythematosus patients
    Jia, Linjia
    Levine, Alana B.
    Lockshin, Michael D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (07) : 1502 - 1503
  • [22] Diagnostic dilemmas - Systemic lupus erythematosus and antiphospholipid antibody syndrome
    Lin, P
    Phillips, TJ
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2002, 14 (06): : 221 - 226
  • [23] Shrinking Lung Syndrome Diagnostic and Therapeutic Challenges in 3 Patients With Systemic Lupus Erythematosus
    Ciaffi, Jacopo
    Gegenava, Maka
    Ninaber, Maarten K.
    Huizinga, Tom W. J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) : S525 - S529
  • [24] The criteria-dependent risk of systemic lupus erythematosus developing in patients with discoid lupus erythematosus
    Heymann, Warren R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : 539 - 540
  • [25] Classification criteria for systemic lupus erythematosus
    Van Epps, Heather
    Clark, Anna
    LANCET RHEUMATOLOGY, 2019, 1 (02): : E83 - E83
  • [26] Systemic lupus erythematosus criteria nowadays
    Cervera, Ricard
    MEDICINA CLINICA, 2022, 159 (04): : 187 - 188
  • [27] CRITERIA FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    RABHAN, NB
    MINKIN, W
    ARCHIVES OF DERMATOLOGY, 1974, 110 (05) : 807 - 807
  • [28] Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus
    Merrill, JT
    LUPUS, 2004, 13 (11) : 869 - 876
  • [29] "EXTRA"- CRITERIA ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS (PRELIMINARY DATA)
    Cheldieva, F.
    Reshetnyak, T.
    Cherkasova, M.
    Seredavkina, N.
    Lila, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 605 - 606
  • [30] Management of Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus
    Mary-Clair Yelovich
    Kimberly J. Legault
    Current Treatment Options in Rheumatology, 2019, 5 : 190 - 200